title: Nursing considerations for patients receiving pazopanib for renal cell carcinoma.
authors.forename: Elisa
authors.initials: E
authors.lastname: Becze
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy / Q000451:nursing*; D006801:Humans; D007191:Indazoles; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000451:nursing*; D011743:Pyrimidines / Q000009:adverse effects / Q000627:therapeutic use*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D007191:Indazoles; D011743:Pyrimidines; D013449:Sulfonamides; C516667:pazopanib